Logo
Login
$TRVI
$13.35 +$0.84 (6.71%) Close

Company Executives

$TRVI Management Team

Dr. David Meeker

Independent Chairman of the Board

Age 69
Compensation $143.2K USD
Sex Male

Dr. Thomas Sciascia

Co-Founder

Chief Scientific Officer

Age 71
Compensation $977.1K USD
Sex Male

Dr. James Cassella

Chief Development Officer

Age 70
Compensation $1.547M USD
Sex Male

Dr. Farrell Simon

Chief Commercial Officer

Age 43
Compensation -
Sex Male

Mr. Jonathan Carlson

IR Contact Officer

Age -
Compensation -
Sex Male

Ms. Jennifer Good

President

Chief Executive Officer

Director

Age 60
Compensation $2.589M USD
Sex Female

Mr. David Hastings

Chief Financial Officer

Age 64
Compensation -
Sex Male

Board of Directors

From the proxy statement filed Apr 21, 2026
Directors
6
serving now
Independent
0 of 1
stated in the proxy; 5 not stated
Average tenure
9.3 years
from year joined
CEO also chairs the board
No
David Meeker
Director Age On board Independent Committees Other public boards 2025 pay Source
Michael Heffernan
Not stated 2017
9 years
 Not stated
audit compensation
Avalo Therapeutics, Inc., enGene Holdings Inc., Biohaven LTD $283,430
Dominick Colangelo
Not stated 2020
6 years
 Not stated
audit compensation
Vericel Corporation $275,930
Edward Mathers
Not stated 2017
9 years
 Not stated
compensation
Synlogic, Inc. $265,930
David Meeker
Board chair
 Not stated 2017
9 years
 Not stated
nominating and corporate governance
Rhythm Pharmaceuticals, Inc., Pharvaris B.V. $293,430
Jennifer Good
CEO
 Not stated 2011
15 years
 Not independent None stated Rhythm Pharmaceuticals, Inc. Paid as CEO
Anne VanLent
Not stated 2018
8 years
 Not stated
audit · Chair nominating and corporate governance
None stated $283,430

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 21, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans